Skip to main content

What the FDA labels say about taking them together

Carmustine and phenobarbital

Carmustine's FDA label of April 9, 2026 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name carmustine. The carmustine label: “DRUG INTERACTIONS Cimetidine: Increased myelosuppression with concomitant use. Phenobarbital: Induces carmustine metabolism, reducing exposure.”

Check it at the source: the carmustine FDA label on DailyMed (effective April 9, 2026, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the carmustine label say about phenobarbital?

Carmustine label, drug interactions

DRUG INTERACTIONS Cimetidine: Increased myelosuppression with concomitant use. (7.1) Phenobarbital: Induces carmustine metabolism, reducing exposure.

Source: FDA drug label (CARMUSTINE), Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effective April 9, 2026 (SPL set b9b47082-32ee-4abb-a7b2-52292894d3f8), via openFDA; the full label on DailyMed

What does the phenobarbital label say about carmustine?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name carmustine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Carmustine generic labelers
0Phenobarbital generic labelers
CarmustinePhenobarbital
Labeled forLeukemia, lymphoma and myelomaSeizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)n/a$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?